CIP
Chartwell Investment Partners Portfolio holdings
AUM
$2.91B
1-Year Return
40.48%
This Quarter Return
+2.96%
1 Year Return
+40.48%
3 Year Return
+57.19%
5 Year Return
+149.04%
10 Year Return
+395.35%
AUM
$2.85B
AUM Growth
-$37.4M
(-1.3%)
Cap. Flow
-$87.5M
Cap. Flow
% of AUM
-3.07%
Top 10 Holdings %
Top 10 Hldgs %
20.58%
Holding
444
New
35
Increased
139
Reduced
222
Closed
34
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
$9.1M |
| 2 |
Intercontinental Exchange
ICE
|
$8.37M |
| 3 |
Intel
INTC
|
$8.01M |
| 4 |
Methanex
MEOH
|
$7.66M |
| 5 |
CNX Resources
CNX
|
$7.58M |
Top Sells
| 1 |
Dycom Industries
DY
|
$16.5M |
| 2 |
Mueller Water Products
MWA
|
$12.2M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$11.9M |
| 4 |
Applied Materials
AMAT
|
$10.1M |
| 5 |
Diamondback Energy
FANG
|
$8.27M |
Sector Composition
| 1 | Technology | 25.63% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 11.98% |
| 4 | Industrials | 9.97% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Constellation Energy
CEG
$93.4B
| $594K | 0.02% |
2,965
-8,591
| -74% | -$1.72M |
|
377
ANI Pharmaceuticals
ANIP
$2.04B
| $587K | 0.02% |
9,226
-1,500
| -14% | -$95.4K |
|
378
Bloomin' Brands
BLMN
$620M
| $587K | 0.02% |
30,538
-33,957
| -53% | -$653K |
|
379
Voya Financial
VOYA
$7.42B
| $579K | 0.02% |
8,141
-8,583
| -51% | -$610K |
|
380
Huron Consulting
HURN
$2.51B
| $564K | 0.02% |
5,719
-936
| -14% | -$92.3K |
|
381
Valvoline
VVV
$4.96B
| $544K | 0.02% |
12,600
-13,511
| -52% | -$583K |
|
382
Liquidia Corp
LQDA
$2.45B
| $524K | 0.02% |
43,693
-7,140
| -14% | -$85.6K |
|
383
AST SpaceMobile
ASTS
$11.2B
| $523K | 0.02% |
+45,035
| New | +$523K |
|
384
IDEAYA Biosciences
IDYA
$2.29B
| $521K | 0.02% |
14,815
-2,426
| -14% | -$85.3K |
|
385
Labcorp
LH
$22.9B
| $521K | 0.02% |
2,559
-2,918
| -53% | -$594K |
|
386
Weatherford International
WFRD
$4.48B
| $521K | 0.02% |
4,259
-691
| -14% | -$84.5K |
|
387
MYR Group
MYRG
$2.75B
| $507K | 0.02% |
3,737
-3,340
| -47% | -$453K |
|
388
Biohaven
BHVN
$1.69B
| $496K | 0.02% |
14,290
-2,340
| -14% | -$81.2K |
|
389
Immunovant
IMVT
$2.85B
| $474K | 0.02% |
17,941
-2,924
| -14% | -$77.3K |
|
390
Axsome Therapeutics
AXSM
$6.13B
| $464K | 0.02% |
5,763
-943
| -14% | -$75.9K |
|
391
Evolus
EOLS
$488M
| $441K | 0.02% |
40,643
+16,550
| +69% | +$180K |
|
392
ACM Research
ACMR
$1.74B
| $432K | 0.02% |
+18,771
| New | +$432K |
|
393
Amneal Pharmaceuticals
AMRX
$2.97B
| $432K | 0.02% |
+67,933
| New | +$432K |
|
394
Vera Therapeutics
VERA
$1.42B
| $424K | 0.01% |
+11,725
| New | +$424K |
|
|
CTLT
395
DELISTED
CATALENT, INC.
CTLT
| $414K | 0.01% |
7,348
-1,182
| -14% | -$66.6K |
|
396
Dutch Bros
BROS
$8.95B
| $391K | 0.01% |
+9,449
| New | +$391K |
|
397
Merus
MRUS
$4.99B
| $367K | 0.01% |
+6,193
| New | +$367K |
|
398
Cabot Corp
CBT
$4.32B
| $366K | 0.01% |
3,984
-641
| -14% | -$58.9K |
|
399
Corning
GLW
$60.3B
| $322K | 0.01% |
8,293
-31,918
| -79% | -$1.24M |
|
400
Synaptics
SYNA
$2.72B
| $277K | 0.01% |
3,139
-508
| -14% | -$44.8K |
|